Bibliography
- SCHUIJT MP, TOMB, DE VRIES R et al.: Superoxide does not mediate the acute vasoconstrictor effects of angiotensin II: a study in human and porcine arteries. Hypertens. (2003) 21:2335–2344.
- BATENBURG WW, GARRELDS IM, VAN KATS JP, SAXENA PR, DANSER AHJ: Mediators of bradykinin-induced relaxation in human coronary microarteries. Hypertension (2004) 43:488–492.
- HWA JJ, GHIBAUDI L, WILLIAMS P,CHATTERJEE M: Comparison of acetylcholine-dependent relaxation in large and small arteries of rat mesenteric vascular bed. Am.j Physiol (1994) 266:H952–H958.
- GAUTHIER KM, JAGADEESH SG, FALCK JR, CAMPBELL WB: 14,15-Epoxyeicosa-5(Z)-enoic-mSI. A 14,15- and 5,6-EET antagonist in bovine coronary arteries. Hypertension (2003) 42:555–561.
- CHAUHAN SD, NILSSON H, AHLUWALIA A, HOBBS AJ: Release of C-type natriuretic peptide accounts for the biological activity of endothelium-derived hyperpolarizing factor. Proc. Natl. Acad. ScLUSA (2003) 100:1426–1431.
- NGUYEN G, DELARUE F, BURCKLE C,BOUZHIR L, GILLER T, SRAER J-D: Pivotal role of the reniniprorenin receptor in angiotensin II production and cellular responses to renin. Clin. Invest. (2002) 109:1417–1427.
- SARIS JJ, VAN DEN EIJNDEN MMED, LAMERS JMJ, SAXENA PR, SCHALEKAMP MADH, DANSER AHJ: Prorenin-induced myocyte proliferation: no role for intracellular angiotensin II. Hypertension (2002) 39:573–577.
- GROSKOPF JC, SYU LJ, SALTIEL AR, LINZER DIH: Proliferin induces endothelial cell chemotaxis through a G protein- coupled, mitogen-activated protein kinase-dependent pathway. Endocrinology (1997) 138:2835–2840.
- KOHLSTEDT K, BRANDES RP, MOLLER-ESTERL W, BUSSE R, FLEMING I: Angiotensin-converting enzyme is involved in outside-in signaling inendothelial cells. Circ. Res. (2004) 94:60–67.
- VAN ESCH JHM, TOM B, DIVE V, BATENBURG WW et al.: Selective angiotensin-converting enzyme C-domain inhibition is sufficient to prevent angiotensin I-induced vasoconstriction Hypertension (2005) 45:120–125.
- WOLLERT KC, MEYER GP, LOTZ J et al: Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet (2004) 364:141–148.